Amgen Technology (Ireland) Unlimited Company Sustainability Profile
Amgen Technology (Ireland) Unlimited Company, a subsidiary of the global biotechnology leader Amgen Inc., is headquartered in Ireland (IE) and plays a pivotal role in the biopharmaceutical industry. Founded in 1980, Amgen has established itself as a key player in the development of innovative therapies, particularly in the fields of oncology, nephrology, and inflammation. With major operational regions across Europe, Amgen Technology focuses on delivering cutting-edge biologic medicines that address serious illnesses. The company is renowned for its unique products, including monoclonal antibodies and biosimilars, which are designed to improve patient outcomes. Amgen's commitment to research and development has led to significant milestones, solidifying its market position as a leader in biotechnology. The company continues to achieve notable advancements, contributing to the evolution of healthcare and enhancing the quality of life for patients worldwide.
DitchCarbon Score
How does Amgen Technology (Ireland) Unlimited Company's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Amgen Technology (Ireland) Unlimited Company's score of 44 is higher than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Amgen Technology (Ireland) Unlimited Company currently does not have specific carbon emissions data available for the most recent year. As a current subsidiary of Amgen Inc., any climate commitments or emissions data would be inherited from its parent company. Amgen Inc. has established various climate initiatives, including Science-Based Targets Initiative (SBTi) commitments, which aim to significantly reduce greenhouse gas emissions across its operations. However, specific reduction targets or achievements for Amgen Technology (Ireland) Unlimited Company are not detailed in the available information. The company is part of a broader commitment to sustainability and climate action, aligning with industry standards and practices. While no absolute emissions figures are provided, Amgen Inc.'s overarching climate strategies reflect a dedication to reducing environmental impact and promoting sustainable practices within the biotechnology sector. As of now, Amgen Technology (Ireland) Unlimited Company has not disclosed specific reduction targets or initiatives at the subsidiary level, but it is expected to follow the climate commitments set forth by its parent company, Amgen Inc.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 144,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 290,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | - | - | - | - | - | - | 000,000,000 | 000,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - | - | - | 00,000,000 | 00,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | - | - | - | - | - | - | - |
How Carbon Intensive is Amgen Technology (Ireland) Unlimited Company's Industry?
How Carbon Intensive is Amgen Technology (Ireland) Unlimited Company's Location?
Amgen Technology (Ireland) Unlimited Company's Scope 3 Categories Breakdown
Amgen Technology (Ireland) Unlimited Company's Scope 3 emissions, which increased by 83% last year and increased by approximately 99% since 2013, demonstrating supply chain emissions tracking. Their carbon footprint includes supplier sustainability and value chain emissions data across Scope 3 categories, with "Business Travel" being the largest emissions source at 46% of Scope 3 emissions.
Top Scope 3 Categories
Amgen Technology (Ireland) Unlimited Company's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Amgen Technology (Ireland) Unlimited Company has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
